Medicare Ends Automatic Extra Payments for FDA 'Breakthrough' Medical Devices

Medicare will no longer automatically provide enhanced reimbursement for medical devices that receive FDA breakthrough designation. The change marks a significant shift in how the agency supports innovative medical technology, as these devices previously received expedited coverage and higher payment rates. Breakthrough devices are those expected to provide more effective treatment for life-threatening or irreversibly debilitating conditions. This policy modification may slow adoption of cutting-edge medical innovations and affect manufacturers' ability to recoup development costs. Patients and healthcare providers should understand that access to and affordability of newly approved breakthrough devices may be impacted by this Medicare decision.